Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
This study evaluated the safety of Olanzapine for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockResearchers compared ALKS 3831 and Olanzapine to find out how the approaches affected body weight in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockA Phase 1, Randomized, Double-blind, Placebo-controlled, Multiple-dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ALKS 9072 in Subjects With Chronic Stable Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including AtlantaThis study evaluated the effectiveness of Aripiprazole for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including AntwerpThis study evaluated the safety of Aripiprazole Lauroxil for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockThis study evaluated the safety and effectiveness of Paliperidone Palmitate for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockResearchers studied Cariprazine to find out how it affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Costa MesaA Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockA Randomized, Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Extension Evaluating Paliperidone Extended Release Tablets in the Prevention of Recurrence in Subjects With Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedA Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Phase 1 Study to Compare the Tolerability of OROS Paliperidone (Extended Release) With Immediate-release (IR) Risperidone in Subjects With Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedResearchers studied Paliperidone ER to find out how it affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedResearchers studied Lurasidone, tracking side effects to assess safety in people with schizophrenia.
This study has finished and is no longer accepting participants.
In TaipeiWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.